학술논문
A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
Document Type
Abstract
Author
Voorhees, Peter M.; D'Souza, Anita; Weisel, Katja; Hurd, David Duane; Teipel, Raphael ; Chung, Alfred; Rodriguez, Cesar; Tuchman, Sascha A.; Korde, Neha; Safah, Hana; Bueno, Orlando F.; Pumford, Neil ; Rosenberg, Tanya S ; Pothacamury, Rajvineeth Kumar ; Ross, Jeremy A. ; Polepally, Akshanth R. ; Lee, Shane ; Jin, Ziyi ; Talati, Chetasi ; Vij, Ravi ; Kumar, Shaji K
Source
In Blood 15 November 2022 140 Supplement 1:4401-4404
Subject
Language
ISSN
0006-4971